Joseph Petroziello | Vice President-Scientific and Corporate Communications |
Chaim Lebovits | President and Chief Executive Officer |
Eyal Rubin | Executive Vice President and Chief Financial Officer |
Ralph Kern | Chief Operating Officer and Chief Medical Officer |
David Bautz | Zacks Investment Research |
Caroline Palomeque | Maxim Group |
Jason Kolbert | H.C. Wainwright |
Good day and welcome to the BrainStorm Cell Therapeutics' Third Quarter 2018 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Joseph Petroziello, Vice President of Scientific and Corporate Communications at BrainStorm. Please go ahead.
Thank you, operator.